Monopar Therapeutics MNPR Net Income
Net Income at other companies
Other financials
Where this comes from
Reported directly by Monopar Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The official record: Monopar Therapeutics’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Monopar Therapeutics's net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Monopar Therapeutics's net income?
- Monopar Therapeutics (MNPR) reported net income of -$3.89M in Q1 2026.
- How has Monopar Therapeutics's net income changed year-over-year?
- Monopar Therapeutics's net income decreased by 48.3% year-over-year, from -$2.62M to -$3.89M.
- What is the long-term trend for Monopar Therapeutics's net income?
- Over 4 years (2021 to 2025), Monopar Therapeutics's net income has grown at a 10.8% compound annual growth rate (CAGR), from -$9.1M to -$13.72M.
- What does net income mean?
- The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.